Publication | Open Access
Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions
37
Citations
20
References
2019
Year
Inhibiting PSAT1 might aid in the treatment of lung cancer, and PSAT1 may be a therapeutic target for lung cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1